XYNTHA
Google image searchProduct monograph
Active ingredient
moroctocog alfa, 250 UNIT/VIAL
DIN: 02309483
Dosage form(s): KIT, POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Schedule D
Company: PFIZER CANADA ULC
Date: 17-FEB-2012
ATC:
- B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
- B02B — VITAMIN K AND OTHER HEMOSTATICS (ATC, ATC/DDD)
- B02BD — Blood coagulation factors (ATC, ATC/DDD)
- B02BD02 — COAGULATION FACTOR VIII (ATC/DDD)
Reference brand drug: Adynovate, Eloctate, Esperoct, Jivi, Kovaltry, Nuwiq, Obizur, Xyntha, Zonovate
